INTRODUCTION
The incidence of atopy and asthma has greatly increased over recent years, concomitant with an improved hygienic status in the industrialized world. This suggests some form of environmental control on the development of allergic diseases. The hygiene hypothesis was invoked in 1989 to explain the inverse relationship between the risk of an allergic disease, hay fever, and family size. 1 This hypothesis contends that in recent years, reduced microbial exposure in early life because of improved sanitary conditions and altered lifestyles has caused an increase in allergic diseases including asthma in developed countries. Several studies have supported the concept of the hygiene hypothesis. For example, an inverse association was noted between delayed-type hypersensitivity responses to tuberculin, a measure of responses to Mycobacterium tuberculosis , and serum immunoglobulin E titer, an indicator of the allergic burden. 2 A lower incidence of allergic disease was reported in children enrolled early in day care. 3 High levels of endotoxin, measured in dust samples collected from mattresses, was shown to be inversely related to the occurrence of hay fever, atopic asthma, and atopic sensitization among children raised in farms in rural areas in Europe. 4 Initially, this observed inverse relationship between lipopolysaccharide (LPS) and allergic disease was attributed to (T helper (Th)1 / Th2) cross-regulation. 2, 5 However, it has become apparent after many studies that the underlying mechanism of the hygiene hypothesis is not Th1 / Th2 cross-regulation. For example, in the studies of Braun-Fahrlander et al., 4 LPS exposure was found to correlate with the inability of the children ' s blood leukocytes to produce both Th1 and Th2 cytokines, showing an overall downregulation of immune responses. It should be noted that not only have atopic diseases been on the rise in recent years, but so have autoimmune diseases such as diabetes mellitus and multiple sclerosis, 6 such that investigators have begun to search for a common denominator for this increase in immune-mediated disorders. The contribution of LPS has been associated with both promotion and inhibition of allergic airway inflammation. A dose < 1 ng of LPS induces tolerance, ~ 100 ng promotes allergic airway inflammation, whereas a higher dose ( g range) inhibits the same process. 8, 9 LPS in the range of 30,000 endotoxin units (3 g ) per m 2 of mattress surface area was detected in farms in which children were found to be protected from allergic diseases including hay fever and asthma. 4 We examined the effect of different doses of LPS on the frequency of CD11b + Gr1 + cells, as this dual expression would be expected to reveal neutrophils, which should be recruited by LPS to the lungs. Interestingly, LPS not only caused the expected increase in the frequency of a CD11b + Gr1 hi population, but also a second population, with the phenotype CD11b + Gr1 int also promoted by LPS ( Figure 1a ). The frequency of the CD11b + Gr1 int population increased with each instillation of LPS and was discernible as early as 24 h after the first instillation.
To characterize each population further, the cells were sorted as shown ( Figure 1b ). As expected, the Gr1 hi population showed myleoperoxidase activity characteristic of neutrophils but the Gr1 int cells did not express myleoperoxidase ( Figure 1c ).
The cells were also examined for the expression of F4 / 80, which is not expressed by neutrophils. 10, 11 Although the neutrophils were F4 / 80 − , the Gr1 int cells were F4 / 80 + . Collectively, the features of the Gr1 int cells resembled those of myeloidderived suppressor cells (MDSCs) isolated from tumor sites that have the phenotype CD11b + Gr1 + F4 / 80 + . 12 We also examined the expression of other molecules such as CD115 (M-CSF receptor), CD124 (interleukin-4 (IL-4) receptor chain), CD62L, CD34, and CD206, which have been associated with tumor-infiltrating MDSCs. 13 However, the expression of these molecules is not essential for the suppressive function of MDSCs. 12 The CD11b + Gr1 int F4 / 80 + cells induced by LPS in the lung did not express CD115, CD124, CD62L, CD34, or CD206 ( Figure 1d ). The LPS-induced cells also expressed intermediate / low levels of CD11c. As shown in Figure 1e , the Gr1 hi and Gr1 int populations were morphologically distinct. As expected, the CD11b + Gr1 hi F4 / 80 − cells showed neutrophil-like morphology with characteristic lobular-shaped nuclei. Morphological assessment of CD11b + Gr1 int F4 / 80 + cells revealed the presence of myeloid cells similar to the Gr1 + CD11b + cells described in murine models of cancer and trauma with many cells showing the presence of ring-shaped nuclei. 12 -14 As specific antibodies recognizing the two epitopes of Gr1, Ly6C and Ly6G, are available (anti-Gr1 recognizes both), we also characterized the LPS-induced Gr1 int cells on the basis of expression of the two epitopes. The non-neutrophilic LPSinduced cells consisted of two subsets based on their differential Ly6C expression. Among the CD11b + cells gated on F4 / 80 expression, Ly6G int Ly6C − was the dominant population expanded by LPS treatment, with the Ly6G int Ly6C lo population being the minor subset (right panel in Supplementary Figure S1 online ). As inflammatory monocytes express Ly6C but do not express Ly6G, 15 the Gr1 int cells did not seem to be inflammatory monocytes.
The CD11b + Gr1 int F4 / 80 + cell type is phenotypically distinguishable from lung DCs
We next compared the Gr1 int cells with conventional DCs (cDCs) isolated side-by-side from the lungs of the same LPStreated mice, the DCs being identified based on CD11c expression and low autofluorescence ( Figure 2a ). The cells were cultured briefly to identify the cytokines they produce. The CD11b + Gr1 int F4 / 80 + cells produced higher levels of IL-6 and GM-CSF when compared with equal numbers of cultured cDCs ( Figure 2b ). The cDCs, however, secreted more IL-12p40 ( Figure 2b ). The cDCs expressed higher levels of cell surface markers such as major histocompatibility complex class II, CD86, and CD40, and the reverse was true for CD80 ( Figure 2c ). High level of CD80 expression is a characteristic of MDSCs and is important for their suppressive function. 16 The CD11b + Gr1 int cells have considerable similarity to MDSCs, including the expression of CD80. Given that the Gr1 int cells resembled MDSCs, we also examined nitric oxide (NO) production by the cells and, as shown in Figure 2d , the cells produced NO that was more than that produced by cDCs. For convenience, from here on we have referred to the LPS-induced myeloid cells as CD11b + Gr1 int to distinguish them from neutrophils that are CD11b + Gr1 hi and lung cDCs in which this phenotype has not been encountered.
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Lineage neg progenitors develop into CD11b + Gr1 int cells in the lung in the presence of LPS but do not migrate to draining LNs A previous study showed that migratory hematopoietic stem and progenitor cells (HSPCs) proliferate within extramedullary tissues such as the lungs and kidneys in response to LPS and give rise to myeloid cells that express CD11c with a subset also expressing Gr1 at intermediate levels. 7 It was suggested that an important function of the migratory HSPCs is rapid expansion into innate cells of the immune system after sensing danger signals such as TLR agonists, so that an aggressive immune response can be expeditiously mounted against the invading pathogen. 7 We, therefore, wished to determine whether infusion The earlier study also showed that the HSPCs lack CCR7 and do not migrate to LN draining tissues. 7 To further determine the similarity of the previously described HSPC-derived cells, we also stained cells with anti-CCR7. The CD11b + Gr1 int cells isolated from the lung were all largely CCR7 − , whereas CD11c + CCR7 + cells were detected in the lung ( Figure 3b ). CD11b + Gr1 int cells were not detectable in the LNs of the LPS-treated mice ( Figure  3c ). However, as expected, we observed an ~ 30-fold increase in the number of DCs in the LN upon LPS treatment ( Figure 3c ). Given that these data showed that the CD11b + Gr1 int cells do not traffic to the lung-draining LNs, we reasoned that effects on CD4 + T cells in the LNs such as proliferation would not be any different in LPS-treated mice when compared with that in the LNs of control mice. Indeed, LPS administration into the lungs of mice did not cause inhibition of proliferation of CD4 + T cells in LNs as studied by transfer of carboxyfluorescein succinimidyl ester (CFSE)-labeled naive CD4 + T cells and assessment of CFSE dilution in proliferating cells ( Figure 3d ).
High LPS dose blunts allergen-induced allergic airway inflammation and Th2 effector function in the lung
As our experiments suggested that the LPS-induced CD11b + Gr1 int cells did not traffic to the lung-draining LNs, as was also observed in the previous study, 7 our next question was whether these cells would temper effector T-cell responses in the tissue. We chose a mouse model of allergic airway inflammation induced by the common household allergen, house dust mite (HDM) ( Figure  4a ). Mice were sensitized and challenged with HDM. 17 After one instillation of HDM and allowing time for priming, we assessed IL-5 + CD4 + T cells by enzyme-linked immunosorbent spot (ELISPOT) assay in the lung-draining LNs. As shown in Figure  4b , significantly greater numbers of IL-5 + CD4 + T cells were discernible in the LNs of both HDM and HDM + LPS groups when compared with that in the LNs of naive mice, again showing that a high dose of LPS had minimal effects at the LN level. The slightly lower numbers of IL-5 + cells under conditions of HDM + LPS should be considered in light of the fact that activated T cells can enter LNs from tissues through afferent lymphatics. 18 Thus, the number of effector T cells in the draining LNs after immunization is governed by two criteria -cells that remain in the LN and those that migrate to the antigen-delivery site and re-enter the LN through the afferent lymph. As all of our evidence indicated that the CD11b + Gr1 int cells develop in the lung without detectable presence in the LNs, we did not expect to see any influence on effector response in the LNs soon after priming, which is what we observed. However, when the lungs were examined after three rounds of challenges with the allergen alone or in the presence of LPS, a significant reduction in airway inflammation as well as Th2 cytokine levels in the lung was observed when LPS was mixed with HDM ( Figure 4 c and d ) . Thus, LPS treatment induced a condition in the lung that did not favor effector Th2 responses. Most importantly, LPS did not cause more interferon-production in the lung, suggesting that the inhibition was not due to cross-regulation by this cytokine. If our inference was correct that the LPSinduced tissue-dwelling myeloid cells would suppress Th2 effector function in the lung, we expected in vitro-generated Th2 cells to be unable to induce inflammation in the airways of LPS-treated mice. To test this, Th2 cells were generated in vitro by repetitive stimulation of CD4 + (DO11.10) T cells under Th2-skewing conditions. The cells were then adoptively transferred into control and LPS-treated mice and the cells were recruited to the lung by challenge with aerosolized ovalbumin (OVA). 19, 20 There was a remarkable difference in the level of airway inflammation between the LPS-treated and untreated groups, with severe inhibition observed when cells were transferred into LPS-treated mice ( Figure 4e ). 
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This observation was in line with a previous report in which intravenous LPS administration was shown to suppress experimental asthma in a nitric oxide synthase 2 (NOS2)-dependent manner, although the mechanism for this observation was not identified. 9
LPS-induced development of CD11b + Gr1 int cells is dependent on MyD88 but not TRIF and inhibition of eosinophilic inflammation by LPS is abolished without MyD88
Our next aim was to determine which of the TLR4-induced pathways, myeloid differentiation factor 88 (MyD88) dependent or 
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independent (through TIR-domain-containing adapter-inducing interferon-β (TRIF)), was responsible for the generation of our cell of interest. To match their genetically altered counterparts, wild-type (WT) control mice used for the MyD88 − / − mice were on Balb / c background, whereas those for the TRIF − / − animals were on C57BL / 6 background. We were able to generate the ( Figure 1d ), but at a lower level compared with expression by lung cDCs. The GM-CSF + LPSinduced cells also expressed Gr1 and Thy1.2, the latter being only found on the in vitro -generated cells. Interestingly, Thy1.2 expression on a minor subset of splenic CpG oligodeoxynucleotideinduced CD11c + DCs was previously described. 21 MyD88, but not TRIF, deficiency blocked generation of Gr1 + cells from bone marrow cells in the presence of GM-CSF and LPS ( Figure 5a ). Figure 4 ). Recently, Der p 2 ( Dermatophagoides pteronyssinus group 2), a key allergen of HDM, was shown to be a mimic of the TLR4-associated adaptor MD-2 and provide this essential component of LPS-induced TLR4 signaling in lung epithelial cells that lack MD-2. 22 Similarly, TLR4 signaling in epithelial cells was shown to be important for HDM-induced allergic airways disease. 23 In line with these observations, the MyD88 − / − mice mounted less airway inflammatory response, although it was not totally absent ( Figure 5c ). Interestingly, almost twice the number of cells could be recovered in the bronchoalveolar lavage (BAL) fluid when LPS was administered together with HDM in the MyD88-deficient mice compared with that obtained with HDM alone ( Figure 5c ). The results of these experiments showed that the absence of MyD88 abolishes the suppressive function of a high dose of LPS. However, given that the TRIF / type I interferon pathway stimulates the expression of costimulatory molecules, 24 it is likely that LPS augmented HDM-induced airway inflammation in MyD88 − / − mice not only because of a reduction in the number of CD11b + Gr1 int cells in the absence of MyD88 but also because of preservation of the second pathway, TRIF, downstream of TLR4. Along with increased eosinophilic airway inflammation, the HDM / LPS combination also yielded more IL-5 in the lung when compared with treatment with HDM alone ( Figure 5c ).
Activation of Th2-primed cells by lung DCs is inhibited by CD11b + Gr1 int cells with effects on STAT5 phosphorylation and GATA-3 expression
We next sought to determine whether the CD11b + Gr1 int cells could block activation of transcription factors such as STAT5 and GATA-3 in freshly primed Th2 cells. GATA-3 is the key 
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regulator of Th2 differentiation, as previously described by us and others, 25 -29 and a role for STAT5 in Th2 differentiation has also been shown. 30, 31 The protocol of priming involving 6 days of culture under Th2-skewing conditions does induce GATA-3, although at low levels in a small fraction of the CD4 + T cells, as judged by expression of GATA-3-dependent genes such as T1ST2. 31 Administration of anti-T1ST2 into mice blocks the effector function of adoptively transferred OVA-specific Th2 cells, including Th2 cytokine secretion and eosinophilic airway inflammation. The expression of T1ST2 has been recently ± LPS (10 g LPS per mouse) was administered intratracheally (i.t.) at the indicated time points. Lung-draining lymph nodes (LNs) were harvested from one group 7 days after one HDM instillation ± LPS to assess CD4 + Tcell priming. The rest of the animals were challenged with HDM ± LPS and at 72 h after the final instillation, bronchoalveolar lavage (BAL) fluid and lung tissue samples were obtained. ( b ) Enzyme-linked immunosorbent spot (ELISPOT) assay of cells harvested from lung-draining LNs. Naive mice were used as control. For all the groups, the total cell population was used for ELISPOT assay and the number of cytokine-expressing Th cells was estimated based upon the percentage of CD4 + T cells determined by flow cytometry. For the HDM and HDM + LPS groups, CD4 + T cells were also purified by magnetic bead selection before being subjected to the assay to confirm that the cytokines were being produced by CD4 + T cells. In all cases, cells were stimulated for 8 -10 h with phorbol-12-myristate-13-acetate (PMA; 25 ng ml − 1 ) plus ionomycin (500 ng ml 
shown to require GATA-3 and activated STAT5. 31 We reasoned that if both STAT5 and GATA-3 are required for expression of Th2 cytokine genes and other Th2 expressed molecules such as T1ST2, the efficient Th2 suppression observed in vivo ( Figure 4 ) might be because of the inability of primed Th2 cells migrating into tissue to be reactivated by tissue DCs, resulting in GATA-3 upregulation and STAT5 activation. We, therefore, asked whether stimulatory effects of lung cDCs on the primed Th2 cells would be compromised by the LPS-induced lung CD11b + Gr1 int cells. As measures of Th2 activation, we examined Th2 cytokine production, STAT5 phosphorylation, and GATA-3 expression ( Figure 6 ). The frequency of IL-5-secreting Th2 cells was ascertained by intracellular cytokine staining after coculture of the primed Th2-skewed cells with either lung cDCs, CD11b + Gr1 int cells, or their mixture for 36 h, as shown in Figure 6a . The ratio of DC to CD11b + Gr1 int cells used was 1:5 based on our quantitation of these cells in the lungs after LPS administration over a 4-day time period that ranges from five-to ten-fold more than cDCs. As expected with specific antigen-induced stimulation, and as opposed to phorbol-12-myristate-13-acetate plus ionomycin that would activate all primed T cells, a fraction of CD4 cells showed blast-like (activated) morphology (by forward scatter vs. side scatter, data not shown) as well as typically lower CD4 expression. 32, 33 Among reactivated CD4 cells (reduced CD4 expression), the frequency of IL-5-secreting cells was greater with stimulation by lung cDCs when compared with lung CD11b + Gr1 int cells ( Figure 6a ). In addition, fivefold more CD11b + Gr1 int cells reduced cytokine production by 55.0 ± 3.5 % . However, as expected, the addition of fivefold more lung cDCs slightly increased cytokine production (data not shown). Furthermore, IL-5 production was inhibited when the cDCs were mixed with the CD11b + Gr1 int cells in a 1:5 ratio by 60.7 ± 2.4 % ( Figure 6a ). The inhibition was not reversed when the NOS2 inhibitor L-(1-iminoethyl)lysine (L-NIL) was used. We next cocultured the primed Th2 cells with cDCs or CD11b + Gr1 int cells as above, removed the culture supernatant, and exposed the cells briefly to IL-2 to assess STAT5 phosphorylation. IL-2 was able to induce STAT5 phosphorylation in cells cocultured with lung DCs and same numbers of CD11b + Gr1 int cells but not when fivefold more CD11b + Gr1 int cells were used ( Figure 6b ). When added to cDCs, the cells partially inhibited STAT5 phosphorylation that was reversed by L-NIL. The reversal of suppression by L-NIL was expected, as NO blocks Jak3-mediated STAT5 activation. 34, 35 With respect to GATA-3 expression, lung cDCs induced an increase in GATA-3 expression in the primed Th2 cells. Similar to results obtained for STAT5 phosphorylation, equal numbers of CD11b + Gr1 int cells as cDCs also caused GATA-3 upregulation. However, at fivefold higher numbers and when mixed with DCs, GATA-3 upregulation was not achieved ( Figure 6c ). However, it is noteworthy that the cells maintained a low level of GATA-3 expression. Addition of L-NIL only slightly reversed GATA-3 expression ( Figure 6c ).
Several mediators produced by MDSCs have been shown to mediate their suppressive functions, which include NO, reactive oxygen species, and arginase I (Arg1) 13,36 -38 Using reverse transcriptase-PCR techniques, both Arg1 and NOS2 expression was detected in the CD11b + Gr1 int cells (data not shown). We therefore examined whether the suppressive effect of the lung-derived CD11b + Gr1 int cells could be reversed by inhibiting some of these mediators produced by the cells. As shown in Figure 6d , addition of the Arg1 inhibitor, nor-N(ω)-hydroxy-nor-1-arginine, or use of neutralizing anti-IL-10 antibody completely reversed Th2 cytokine suppression by the CD11b + Gr1 int cells. However, addition of apocynin (inhibitor of NADPH oxidase), uric acid (peroxynitrite scavenger), or L-NIL (specific inhibitor of NOS2) to the coculture did not reverse the suppressive effects of CD11b + Gr1 int cells on cDC-induced IL-13 production from primed Th2 cells ( Supplementary Figure S3  online ) . Thus, although L-NIL partially restored the ability of the Th2 cells to mount STAT5 activation and express GATA-3, it was not able to reverse suppression of cytokine production, which was only achieved by blocking Arg1 and IL-10.
Adoptive transfer of in vitro -or in vivo -induced CD11b + Gr1 int cells inhibit allergen-induced airway inflammation
Because all of our data showed the ability of the CD11b + Gr1 int cells to inhibit the effector function of Th2 cells, we asked whether under post-allergen-sensitized conditions that would mimic human disease, intratracheally transferred CD11b + Gr1 int cells 
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would have the ability to suppress recall responses to an allergen. We used OVA in combination with the mucosal adjuvant cholera toxin that we have previously shown to induce allergic airway inflammation. 39, 40 In vitro -generated CD11b + Gr1 + cells ( 
DISCUSSION
In recent years, the notion that microbial products thwart the development of allergic disease by causing Th2 to Th1 immune deviation has not been supported by scientific evidence. For example, worm infections that induce Th2 responses were also found to be inversely associated with allergic disease, which itself is a Th2-dominated disease. 41 Given that immunosuppressive mechanisms are now thought to be more likely involved in mediating the protective effects of microbial products, 42 we explored the possibility that LPS-induced TLR signaling promotes the development of suppressive cells in the lung, as multiple studies have established an inverse relationship between the level of LPS exposure and the development of asthma and allergy. 4, 8, 9 LPS / TLR4 exerts a range of effects on allergic responses in the lung depending on the target cell and dose. Studies published recently show that TLR4 signaling in lung epithelial cells is important for HDM-induced allergic responses in the lung. Der p 2, an important allergen of HDM, was able to substitute for the TLR4-associated adaptor, MD-2, that is not expressed by lung epithelial cells, thereby providing this essential component of LPS-induced TLR4 signaling in these cells. 22 Another study has also reported on the importance of TLR4 signaling in epithelial cells in HDM-induced allergic airways disease. 23 With regard to the level of exposure, at very low levels ( < 10 ng) LPS induces suppression, 43 whereas at levels of ~ 100 ng, LPS promotes Th2-mediated inflammation because of its adjuvant effects. 8 A high dose of LPS is suppressive for allergic responses in the airways, as shown in multiple studies 8, 9 including this study, but the mechanism has not been investigated before this study.
We have identified a population of LPS-induced CD11b + Gr1 int F4 / 80 + cells in the lung that does not traffic to lung-draining LNs. Indeed, no effect of LPS on T-cell responses such as CD4 Tcell proliferation or Th2 priming was evident in the lung-draining LNs. However, allergen-induced inflammation in the airways was dampened when the allergen was mixed with LPS, and upon adoptive transfer, Th2-primed cells were unable to induce inflammation in LPS-exposed lungs. Together, these observations suggested suppressive effects of the cells localized to the lung tissue. When the effect of the CD11b + Gr1 int cells on Th2-primed cells was examined in vitro , lung DC-induced GATA-3 upregulation and IL-2-induced STAT5 phosphorylation were both inhibited. The development of these cells was dependent on MyD88 but not TRIF. Lack of MyD88 unmasked the TRIF-dependent adjuvant effects of LPS even at a high LPS dose, causing LPS to promote rather than suppress HDM-induced allergic inflammation. When adoptively transferred into mice, the myeloid cells efficiently inhibited allergen-induced airway inflammation.
The cell type identified by us bears close similarity to MDSCs. Although in addition to cancers, MDSCs have been identified in various other pathological conditions, including acute and chronic infections such as worm infections 13,37,44 -46 and trauma, 14 no previous study has explored the possibility that exposure of the lungs to a high dose of LPS might induce MDSC-like myeloid cells that would suppress reactivation of primed Th2 cells. In a previous study, HSPCs that had emigrated from the bone marrow were found to proliferate in extramedullary tissues such as the lung and Figure 7 CD11b + Gr1 int cell-mediated prevention and treatment of eosinophilic airway inflammation in vivo . Mice were antigen sensitized by three daily consecutive intranasal treatments with ovalbumin (OVA) plus cholera toxin (CT) followed by 5 days of rest. CD11b + Gr1 int cells were generated from bone marrow progenitor cells in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF; 10 ng ml − 1 ) and lipopolysaccharide (LPS; 1 g ml − 1 ) and then adoptively transferred intratracheally (1 × 10 6 cells per mouse) into mice that had received OVA / CT. Control mice did not receive any cells. Mice were then challenged with aerosolized OVA daily for 7 days. Total and differential cell counts in the bronchoalveolar lavage (BAL) fluid (upper panel) were enumerated. Values are mean ± s.e.m. * P < 0.05 and * * P < 0.01. Hematoxylin and eosin (H & E) staining (middle panel) of lung sections was performed. Lung infiltrates around bronchovascular bundles were of + 5 grade in animals that did not receive CD11b + Gr1 int cells and + 1 grade in those that did. Interleukin-13 (IL-13) present in lung homogenates (lower panel) was measured by enzyme-linked immunosorbent assay (ELISA) and presented as the mean value ± s.e.m. * P < 0.05.
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respond to LPS, resulting in differentiation into CD11c + myeloid cells, some of which coexpressed Gr1. 7 Although not examined in specific models, it was suggested that the myeloid cells might have immunosurveillance functions, given that they arose in response to TLR agonists such as LPS. Our study shows that the LPS-induced lung-resident cells do have immunomodulatory functions and suppress Th2 effector function without promoting Th1 differentiation. In our experiments, lin neg bone marrow progenitor cells stimulated with a combination of LPS and GM-CSF but not LPS alone yielded CD11b + Gr1 int cells resembling the in vivo-generated cells ( Figure 5 and Supplementary Figure S2 online ). Although LPS administration at a high dose alone was sufficient to promote the development of these cells in the lung, a previous study has implicated GM-CSF in the effects of LPS in the lung. 47 Thus, similar to the ability of GM-CSF to promote LPS-mediated development of these cells in vitro, GM-CSF most likely is also involved in the generation of these cells in vivo . On the basis of the data shown in Figure 3 on the generation of GFP + CD11b + Gr1 int cells from lin neg GFP + cells introduced intravenously into animals, it is possible that HSPCs cells circulating through the lung 7 respond to LPS in situ to generate these cells.
Gr1 + CD11b + cells fall into two subsets in tumor models: cells with granulocytic phenotype that express Ly6G and cells with monocytic phenotype called inflammatory monocytes expressing Ly6C. 48 The two populations with granulocytic vs. monocytic characteristics might have different functions in infectious and autoimmune diseases and cancer. The majority of the LPS-induced myeloid cells in the lung expressed Ly6G, but not Ly6C, and also did not express a range of other molecules expressed by MDSCs such as CD124 and CD115. To our knowledge, there are no reports that have shown the expression of Ly6G on either inflammatory monocytes or monocyte-derived DCs. In fact, Zhu et al. 15 clearly showed that CD11b + Ly6C hi suppressive monocytes are Ly6G negative, further suggesting that the populations we have identified more closely resemble MDSCs. That being said, we feel that the functional distinction between inflammatory monocytes and MDSCs may blur over time as inflammatory monocytes have been shown to possess potent immunosuppressive functions. 15, 49, 50 Continual exposure to LPS causes a selective enrichment of the CD11b + Gr1 int cells in the tissue over cDCs because these cells, unlike the cDCs, are unable to traffic to the LNs because of lack of CCR7 expression ( Figure 3 ). The data in Figure 6 suggest that this enrichment is necessary as similar numbers of CD11b + Gr1 int cells as cDCs are unable to inhibit either STAT5 phosphorylation, GATA-3 expression, or cytokine production by primed Th2 cells but fivefold more cells can. Thus, although increasing lung DC / T cell ratio induces more cytokine expression and transcription factor activation in the T cells, the opposite is true for the CD11b + Gr1 int cells. Moreover, when mixed with cDCs, these cells suppress the ability of cDCs to reactivate primed Th2 cells ( Figure 6 ). We have used the most conservative DC / CD11b + Gr1 int ratio of 1:5 in our experiments, with the numbers of these cells at the LPS dose used over a 4-day time period ranging between five-and ten-fold over cDCs. Inhibition of Th2 cytokine production by the CD11b + Gr1 int cells was reversed using neutralizing anti-IL-10 antibody or the specific Arg1 inhibitor, nor-N(ω)-hydroxy-nor-1-arginine. As IL-10 has been shown to induce Arg1, 51, 52 our data suggest that the IL-10 / Arg1 axis is responsible for the suppressive effect of the myeloid cells on Th2 cytokine production. Interestingly, a similar suppressive effect of Arg1 on Th2 effector function was recently reported in mice infected with the helminth Schistosoma mansoni . 53 Mice lacking Arg1 in macrophages harbored increased levels of Th2 cytokines in the liver of infected mice that was not simply because of increased frequency of the cells. 53 The suppressive effect of Arg1 activity on Th2 effector function is interesting, given that Th2 cytokines actually stimulate Arg1 expression. 54, 55 Thus, it is possible that although Th2 cytokine promotes Arg1 expression, Arg1-stimulated metabolites such as polyamines may function as negative feedback regulators of Th2 effector function. We would propose that the IL-10 / Arg1-mediated inhibition is a dominant mechanism that overrides the activity of key regulators of Th2 cells such as GATA-3 and STAT5. This is because Th2 cytokine production was suppressed by the CD11b + Gr1 int cells despite the ability of the Th2 cells to mount a low level of STAT5 phosphorylation and the presence of a low level of GATA-3 in the cells. In fact, as previously shown by Paul and colleagues 30, 56 , the low level of GATA-3 that is normally present in naive CD4 + T cells is sufficient to synergize with constitutively active STAT5 to induce Th2 cytokine production. Given that a self-amplification loop stimulated by various cytokines is thought to sustain Th2 effector cells, 56 it is possible that the blunting of this response by attenuation of GATA-3 and STAT5 activation and suppression of cytokine production would also negatively affect Th2 memory. This is based on the linear model of Th2 memory in which the memory pool size is directly proportional to the effector pool size. 57 Thus, it will be interesting to determine in future studies the effect of these cells on effector cell survival in vivo .
CD11b + Gr1 + cells were also identified in a model of sepsis but the cells described in this study do not seem to be the kind that we have identified in the lung as the splenic cells in the sepsis model actually promoted Th2 polarization. 46 Although the sepsis model would have involved stimulation by microbial products, and indeed the generation of the CD11b + Gr1 + cells was shown to be dependent on MyD88-dependent signaling, the requirement for functional TLR4 was not evident in the study. 46 In contrast, TLR4 was required for development of the cell in our study ( Figure 5 ). Similar to our findings, the TRIF pathway was not involved in the generation of the splenic CD11b + Gr1 + cells. As despite producing high levels of IL-10, the sepsis-associated CD11b + Gr1 + cells favored Th2 development that was detrimental in the sepsis context, 46 it is possible that unlike the lung cells, the splenic cells do not express Arg1.
In a recent study, prenatal exposure to a non-pathogenic bacterial species was found to protect from allergic airways disease later in the adult mice, the protective effect being dependent on multiple TLRs. 58 Whether such exposures prenatally generated the kind of suppressive cell identified by us remains to be determined. In addition, whether these cells have a role in the development of regulatory T cells will be important to examine, given that cytotoxic T-lymphocyte antigen 4, a ligand of CD80, is expressed at high levels by regulatory T cells and is important for their functions. 59 
In summary, our study has identified the ability of LPS to induce Th2-suppressive myeloid cells in the lung that phenotypically and functionally resemble MDSCs. In the context of allergic airways disease, these cells may have beneficial effects in inhibiting disease pathogenesis, which contrasts with the negative connotation that MDSCs have in most disease contexts. Thus, the CD11b + Gr1 int cells may be the underlying principle of the hygiene hypothesis in the context of protection from allergic asthma. A complete understanding of the generation and regulation of these cells in the lung in response to various pathogens would provide new avenues to either promote or target these cells for therapeutic benefits to develop disease-specific immunoregulation.
